RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Add to Collection
2010 Nov RCTs B Göke, B Gallwitz, J Eriksson… - … journal of clinical …, 2010 - Wiley Online Library

Full Author : ['Goke, B', 'Gallwitz, B', 'Eriksson, J', 'Hellqvist, A', 'Gause-Nilsson, I']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2010
Cited by : 256.0

AIM: To assess the efficacy and safety of saxagliptin vs. glipizide as add-on therapy to metformin in patients with type 2 diabetes mellitus and inadequate glycaemic control on metformin alone. METHODS AND PATIENTS: A total of 858 patients [age >/= 18 yea..... Read More

Keywords : ["type diabetes mellitus inadequately control", "randomise control trial", "metformin alone", "saxagliptin", "patient", "noninferior", "glipizide"]
PubMed Link : https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1742-1241.2010.02510.x
Google Scholar Link : https://scholar.google.com/scholar?cites=3492269449150391233&as_sdt=5,33&sciodt=0,33&hl=en&num=20